AI assistant
INSULET CORP — Director's Dealing 2016
Oct 14, 2016
30258_dirs_2016-10-14_d47fba20-b9f5-4eca-a96c-7e20db10b543.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSULET CORP (PODD)
CIK: 0001145197
Period of Report: 2016-10-12
Reporting Person: SULLIVAN PATRICK J (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-12 | Common Stock | M | 3075 | $32.51 | Acquired | 221544 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-10-12 | Employee Stock Option (Right to Buy) | $32.51 | M | 3075 | Disposed | 2025-03-02 | Common Stock (3075) | Direct |
Footnotes
F1: Includes 777 shares acquired on December 31, 2015 and 674 shares acquired on June 30, 2016 under the Insulet Corporation 2007 Employee Stock Purchase Plan.
F2: Includes 29,100 restricted stock units granted on March 2, 2015, which vest one-half of the total units on March 2, 2017 and one-half of the total units on March 2, 2018; 30,432 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 42,720 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
F3: The transaction referenced in Tables I and II represents the exercise for cash by the reporting person of options to acquire 3,075 shares of the Company's common stock. All of the underlying shares of common stock issued upon exercise of the options have been retained by the reporting person and no sale of common stock occurred in connection with this transaction.
F4: This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.